Protalix BioTherapeutics to report third-quarter financial results

PLX•2026-11-03

Protalix BioTherapeutics will release its third-quarter 2026 financial results and provide a business update on Nov. 10, 2026. Management will host a conference call and webcast at 8 a.m. ET that day.

1. Results and call date

Protalix BioTherapeutics will release its third-quarter 2026 financial results with a business update on Nov. 10. Management will discuss the results and corporate developments during a conference call and webcast at 8 a.m. ET.

Protalix BioTherapeutics to report third-quarter financial results

1. Results and call date

Related News

Rexford Industrial Realty target price raised to $42 from $39

Why SocGen likes European pharma

Energy Transfer Q3 2026 net income attributable to partners rises 18% to $1.21 billion

Sotera Health Q3 revenue beats estimates on pricing and volume

Thomson Reuters posts higher third-quarter revenue, lifts forecast